Abstract

Gambogic acid (GA), a xanthonoid extracted from the resin of the tree, Garcinia hanburyi, was recently shown to exert anticancer activity in multiple studies, but the underlying action mechanism remains unclear. Here, we show that GA induces cancer cell death accompanied by vacuolation in vitro and in vivo. This GA-induced vacuolation in various cancer cells was derived from dilation of the endoplasmic reticulum (ER) and mitochondria, and was blocked by cycloheximide. These findings suggest that GA kills cancer cells by inducing paraptosis, a vacuolization-associated cell death. We found that megamitochondria formation, which arose from the fusion of swollen mitochondria, preceded the fusion of ER-derived vacuoles. GA-induced proteasomal inhibition was found to contribute to the ER dilation and ER stress seen in treated cancer cells, and megamitochondria formation was followed by mitochondrial membrane depolarization. Interestingly, GA-induced paraptosis was effectively blocked by various thiol-containing antioxidants, and this effect was independent of ROS generation. We observed that GA can react with cysteinyl thiol to form Michael adducts, suggesting that the ability of GA to covalently modify the nucleophilic cysteinyl groups of proteins may cause protein misfolding and subsequent accumulation of misfolded proteins within the ER and mitochondria. Collectively, our findings show that disruption of thiol proteostasis and subsequent paraptosis may critically contribute to the anti-cancer effects of GA.

Details

Title
Gambogic acid triggers vacuolization-associated cell death in cancer cells via disruption of thiol proteostasis
Author
Seo Min Ji 1 ; Lee, Dong Min 1 ; Kim In Young 2 ; Lee, Dongjoo 3 ; Min-Koo, Choi 4 ; Joo-Youn, Lee 5 ; Park, Seok Soon 6 ; Seong-Yun, Jeong 6 ; Choi, Eun Kyung 7 ; Choi, Kyeong Sook 1 

 Ajou University Graduate School of Medicine, Department of Biomedical Sciences, Suwon, Korea (GRID:grid.251916.8) (ISNI:0000 0004 0532 3933); Ajou University, Department of Biochemistry and Molecular Biology, Suwon, Korea (GRID:grid.251916.8) (ISNI:0000 0004 0532 3933) 
 Ajou University, Department of Biochemistry and Molecular Biology, Suwon, Korea (GRID:grid.251916.8) (ISNI:0000 0004 0532 3933) 
 Ajou University, Department of Pharmacy, Suwon, Korea (GRID:grid.251916.8) (ISNI:0000 0004 0532 3933) 
 Dankook University, Department of Pharmacy, Cheonan, Korea (GRID:grid.411982.7) (ISNI:0000 0001 0705 4288) 
 Chemical Data-Driven Research Center, Korea Research Institute of Chemical Technology, Daejeon, Korea (GRID:grid.29869.3c) (ISNI:0000 0001 2296 8192) 
 University of Ulsan College of Medicine, Asan Institute for Life Sciences, Department of Convergence Medicine, Asan Medical Center, Seoul, Korea (GRID:grid.267370.7) (ISNI:0000 0004 0533 4667) 
 Asan Medical Center, University of Ulsan College of Medicine, Center for Advancing Cancer Therapeutics, Department of Radiation Oncology, Seoul, Korea (GRID:grid.413967.e) (ISNI:0000 0001 0842 2126) 
Publication year
2019
Publication date
Mar 2019
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2185065113
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.